Alnylam Pharmaceuticals
ALNY
#622
Rank
NZ$56.09 B
Marketcap
$434.87
Share price
2.75%
Change (1 day)
51.12%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company